Strokes after PFA | Hospital sues practice | FDA approves fast-acting drug for children | The cardiologist shortage continues

PFA is still quite safe overall. However, new data out of EHRA 2026 suggest cardiologists have much to learn about minimizing risk during treatment. 

Data on the treatment and management of HFmrEF are limited, but a new scientific statement from the Heart Failure Society of America highlights how important it is to take this condition seriously.

The cardiovascular care of thousands of Missouri patients is suddenly up in the air. The heart of the issue is a practice's alleged interest in opening up a new private equity-backed clinic.  

The Society of Thoracic Surgeons put together an expert committee to examine the prevention and treatment of new-onset postoperative atrial fibrillation after cardiac surgery. The group shared recommendations for before, during and after treatment.

Landiolol, sold under the brand name Rapiblyk, is only meant to be administered in a hospital setting. It was initially approved for adult patients in 2024.

The 22-week-old patient was successfully treated by a traveling cardiologist—all without being transported to the cath lab.

The new clinic wants to keep patients out of hospital EDs when possible and provide care at a lower cost.

AI can help care teams get additional value out of routine head CT images.

Clinlab.AI will oversee every aspect of this new-look laboratory, working to integrate it with the practice's workflows in a way that boosts patient care and speeds up treatment decisions.

Job growth in cardiology is expected to outpace other healthcare specialties in the years ahead. The demand for new cardiologists is so high, however, that the current shortage is not expected to end anytime soon.